Your browser doesn't support javascript.
loading
Distinctive serotypes of SARS-related coronaviruses defined by convalescent sera from unvaccinated individuals.
Tan, Chee Wah; Zhu, Feng; Chia, Wan Ni; Young, Barnaby E; Yeoh, Aileen Ying Yan; Althaus, Thomas; Yung, Chee Fu; Yap, Wee Chee; Lim, Beng Lee; Chen, Mark I-C; Zhang, Jinyan; Mah, Yun Yan; Voiglio, Eric; Sigal, Alex; Huo, Jianxin; Xu, Shengli; Tan, Yee Joo; Lam, Kong-Peng; Lye, David; Wang, Lin-Fa.
Afiliación
  • Tan CW; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
  • Zhu F; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
  • Chia WN; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
  • Young BE; National Center of Infectious Diseases, Singapore.
  • Yeoh AYY; Tan Tock Seng Hospital, Singapore.
  • Althaus T; Lee Kong Chian School of Medicine, Nanyang Technology University, Singapore.
  • Yung CF; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
  • Yap WC; Centre Scientifique de Monaco, Monaco.
  • Lim BL; Direction de I'Action Sanitaire de Monaco, Monaco.
  • Chen MI; Lee Kong Chian School of Medicine, Nanyang Technology University, Singapore.
  • Zhang J; Infectious Disease Service, Department of Pediatrics, KK Women's and Children's Hospital, Singapore.
  • Mah YY; Duke-NUS Medical School, Singapore.
  • Voiglio E; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
  • Sigal A; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
  • Huo J; National Center of Infectious Diseases, Singapore.
  • Xu S; Tan Tock Seng Hospital, Singapore.
  • Tan YJ; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
  • Lam KP; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
  • Lye D; Direction de I'Action Sanitaire de Monaco, Monaco.
  • Wang LF; African Health Research Institute, Durban, South Africa.
Hlife ; 1(1): 26-34, 2023 Nov.
Article en En | MEDLINE | ID: mdl-38994526
ABSTRACT
Multiple Omicron sub-lineages have emerged, with Omicron XBB and XBB.1.5 subvariants becoming the dominant variants globally at the time of this study. The key feature of new variants is their ability to escape humoral immunity despite the fact that there are limited genetic changes from their preceding variants. This raises the question of whether Omicron should be regarded as a separate serotype from viruses serologically clustered with the ancestral severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. Here, we present cross-neutralization data based on a pseudovirus neutralization test using convalescent sera from naïve individuals who had recovered from primary infection by SARS-CoV-1 and SARS-CoV-2 strains/variants including the ancestral virus and variants Beta, Delta, Omicron BA.1, Omicron BA.2 and Omicron BA.5. The results revealed no significant cross-neutralization in any of the three-way testing for SARS-CoV-1, ancestral SARS-CoV-2 and SARS-CoV-2 Omicron subvariants. The data argue for the assignment of three distinct serotypes for the currently known human-infecting SARS-related coronaviruses.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Hlife Año: 2023 Tipo del documento: Article País de afiliación: Singapur

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Hlife Año: 2023 Tipo del documento: Article País de afiliación: Singapur